CPT 89264: Identification of Sperm from Testicular Tissue
Commercial payers pay $183 on average nationally for this procedure.
CPT code 89264 represents laboratory identification of spermatozoa retrieved from fresh or cryopreserved testicular tissue, a specialized andrology laboratory procedure performed to locate viable sperm for use in assisted reproduction; the service is laboratory identification/processing of testicular tissue and the typical site of service is a clinical or hospital-based laboratory supporting reproductive medicine and fertility clinics.
For related coverage guidance, see recent payer policy updates: Oral Cancer Screening and Testing, RTM Testing for Alpha-1 Antitrypsin Deficiency, Cytochrome P450 Genotype-Guided Treatment Strategy Corporate Medical Policy.
Customize your policy alerts
Sign up for cpt 89264 policy alerts
Get alerted when payer policies referencing 89264 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
Commercial reimbursement for CPT 89264 centers around the BUCA average commercial rate of $183.50, with individual payers showing notable variability. Blue Cross Blue Shield (BCBS) and Aetna both have higher upper tails (BCBS max $500, Aetna max $381.70) while Cigna and UnitedHealth Group present elevated upper extremes (Cigna max $850.50, UnitedHealth Group max $651.00). Cigna’s distribution is relatively compressed between the 25th and 75th percentiles ($116.00–$144.30), while Aetna and BCBS span wider interquartile ranges that reflect broader commercial negotiation outcomes.
Assessing dispersion (P75 minus P25) quantifies that UnitedHealth Group is the widest at $288.20 (P75 $353.50 minus P25 $63.00), followed by BCBS at $118.80 and BUCA at $130.60. Cigna is the tightest with a spread of $28.30, indicating more clustered commercial pricing. Aetna’s IQR is $222.00, showing substantial middle-range variability compared with the BUCA average commercial benchmark.